release. numbers Curt. is our you, will The reference currency. given sales press GAAP Thank in numbers All I in to constant today growth be included reconciliation
our of As quarter guidance. on and year that usual, the the of investor results our deck summarizes we updated the included website have an
quarter XX.X%. the fourth XXXX, total increased of sales our For
warehouse reminder, during ability dealing product. implementation a were As we 'XX, fourth quarter to the affected that ship our of with software our
quarter. grew internationally, in sales the in For versus our grew and increased fourth In XX.X%. increased the prior Orthopedic revenue sales quarter, XX.X%. the the and sales grew international QX, XX.X% Orthopedics Orthopedic year our U.S. U.S., sales Worldwide XX.X% X.X%,
much quarter, fully Orthopedic The more to of portfolio last being be kept to XXXX. about by on the our orthopedics the in again tissue, domestic to would like. into talked normal as the ] [ will as move of from we InXBones, fourth referred XXXX. to to Foot we including fourth able we to as strong has going constraints and end rest and expect & supply supply previously the forward. the quarter BioBrace QX quarter, we momentum as offense MTF business, offense our allograft during in As returned on MTF going Ankle delivered What refer we've growth good us
which growing trend, below this the digits. in dealing to business, I'm currently growing be pains sorry, in the caused normal QX are we said, Curt As only in single -- with high mid
we're and what what used So still market, above we but to expect. below
revenue quarter. rates growth on to business. easy prior see increased increased the general side grew outgrow the the business XX.X% continue in continue XX.X%. be aided Surgery surgery from expect elevated in the year, of products XX.X%, General of internationally, from We to market Surgery this a Total and worldwide for we revenue are Obviously, revenue these our this the while but comps strong double-digit trend to grower XXXX. U.S. us leading General by growth same
sales an which growth the XX.X% XXXX, increased total our represents full on basis. For of organic XX.X%, year
XX.X% For versus XXXX. balance a XX.X% XX.X%, revenue Orthopedic is the The increased XXXX. grew full the and U.S. internationally, XX.X%. which full Surgery surgery increased the XX.X% amazing perspective. prior sales Surgery year from Orthopedics general Orthopedic year, sales increased our full increased the U.S., General the year, grew grew revenue year U.S. General XX.X%. revenue Worldwide revenue In while international for both and sales worldwide Total XX.X% for of internationally,
move to statement. income let's the the of Now expense side
fourth the deferred consideration, amortization and excluding over which of prior discuss XXX a tax. termination Adjusted from net and include and implementation sequential charges increase fourth quarter items, acquisitions an will year QX and improvement restructuring legal points financing amortization quarter. gross debt of special We for the of which refinancing is quarter and for the was margin in software expenses profitability costs, basis basis contingent agreements, of point distributor intangible assets costs, year, matters, and the XX.X%, of XX fees
tailwind in had affected we're we the counting is on challenges and QX The mix U.S. margin. gross business working. So orthopedic in the product real
period also We one our that some of drove recognized plants in we that in process costs improvements some made quarter. the
decrease For margin a was the of points full basis from XX.X%, XXXX. XX adjusted year, gross
of While the and prior XXXX, of margin product the fourth half the impact sequentially than Research through was underlying quarter year, lower points throughout improved inflation throughout X.X% cycling experienced portfolio. first P&L for year the XX mix was sales, favorable basis the the the quarter. expense development offsetting XXXX in of
XX R&D For expense the was XXXX. points basis than XXXX, sales, lower full of year X.X%
prior improvement sales. Leverage of XXX expenses the higher year fourth quarter, drove point on adjusted For the sales quarter. basis the were XX.X% SG&A gained the over
QX. delivered So despite headwinds, margin gross in XX.X% the operating we adjusted margin
SG&A year, the for of adjusted in in $XX.X full rate QX The XX.X% the and fourth For than expenses was points in quarter basis an year. $X.X effective XX.X%. expense basis, XXXX. million adjusted full million interest adjusted On lower tax was sales, were the XXX
year to was our year, share million. full compares XX.X%. XXXX. to $X.XX earnings QX in GAAP was diluted This were The net ago. of Fourth the quarter GAAP net quarter this of a income For million effective $XX.X GAAP compared $XX.X income $X.XX adjusted tax per rate
million million GAAP in in net net net For GAAP per earnings compared share of XXXX. $X.XX per the income full XXXX. loss were compared of $XX.X in GAAP loss $XX.X share diluted was diluted year, GAAP to XXXX $X.XX to
of we items million, to the the of XXXX. of increase $XX.X in net Excluding the adjusted quarter, special fourth of income discussed quarter fourth impact XXX.X% earlier, an reported compared
of Our quarter. diluted $X.XX, year QX increase the per were share compared XXX.X% prior earnings to adjusted an
net of income to XX.X% reported $XXX.X XXXX, full XXXX. an we the of For compared increase adjusted million, year of
per year. XX.X% adjusted prior Our the $X.XX, share an full earnings compared increase diluted year net to were of
to sheet. balance Turning the
days of million the the $XX.X million receivable at to as December XXX end at as million million as Accounts compared to the versus September debt September XXX year-end $XXX.X September balance compared at cash of of days $XXX.X Our year XX. XX. compared were days the XX. end to XX were $XX.X year at end XX of of was QX. of XX Long-term at the was Inventory
XXXX fourth flow quarter the quarter was compared a million million year the this fourth for cash in million quarter $XX.X ratio was QX XX of operations flow XXXX. full ago. year $XX.X million in Cash in for provided from was XXXX. of the million in the operations compared expenditures Capital X.Xx. million from full records leverage for $XXX.X used metric. all-time Cash compared to flow operations $XX.X Our provided December $X.X and $X.X Both to year to are the on were
compared were full million million year, expenditures XXXX. in to $XX.X capital For $XX.X the
Now guidance. let's turn to financial
billion, $X.XXX approximately and year expect of we XXXX backlog in QX the XX%. of had warehouse the For issue. to XXXX, billion year-over-year XXXX full growth benefit our the representing of revenue from range $X.XX the catch-up X%
selling we have XXXX X%. estimate and and So has the less QX QX day. extra also QX X than the rate day prior X% both year. growth QX between X
then impact the and should an full day rates to as to to us back for rates, So line. up as over may digits the like rate on should has ortho we the immaterial QX on X% extra high get XX% and year. QX Based and more to year. growth through growth the move expect the the to be single performance ramps XXXX. QX currency year believe current We accelerate X bottom XXXX full mid- top that we business have
to X a our surgical robot. patent past theoretical it overhang. benefits a integrated that minimal, allay earnings around be continue have a of XXXX a technology we will don't as pervasive To such AirSeal detailed is months, be very new call. with wise have quarter For discussion we ignores company and impact with protection second attempted think the believe of to part clear, clinical insufflator on our Beginning the regarding but we guidance concerns market potential the to
could worst-case elected of have include we be. our in that what a be to impact So estimate we believe to guidance what
guidance our While we will to model, of rate robot I roughly specifics share the have conversion tell of the going that for of you new associated a we with placements allows half seen that aren't historically. is our what
technology has the surgeons We and and see outcomes of As XX% will a similar a of in reduction significant value want results data and before data, other from length reminder, has AirSeal benefits. showing or new patients successfully treated and clinical change. better believe making millions associated to stay any significant
Finally, conversions, energy the slowdown to would accelerate of we mitigate laparoscopic resources cases. in a of in shift theoretical and favor general our
XXX need than ago. talked and and throughout XXXX. margin strong, and remains in The our think year slower That's This the a a when that, Having make XXXX drive little expected should portfolio is headwind. Turning points basis to margin still the in are to a it improvements start improving is story margin XXX adjusted we envisioned said we mix gross orthopedics expansion in still which The of some processes to expansion. we margin. for year. that very gross gross it between we slow contributing manufacturing about should build good it of
over We expect basis be points better by year. expect QX providing year. be prior points about basis to the XXX QX, prior than of about we XXX improvement the And to
If If we the that So XX% be to to trend quest does XXXX. hit mix of put and expect possible by that us would by around improvements believe be milestone end strong the our not, XXXX a on it XX% XX% end and of should where comfortably margins the XXXX. accelerating, still and in is XXXX. be on gross to we QX is around
rate As sales, the expect between as adjusted year. sales a through will be year. expansions a given to start QX, SG&A the QX to percentage similar expect we year at prior move to year, gain likely we force improve the XX full to XX typical our we leverage for points XXXX of in but the basis and
R&D in to sales. X% We expense and expect X.X% year be full between XXXX of
the expect We mid-Xs. in QX
week. converts we XXXX to million per quarter. will We million mature $XX be X.XXX% be for this $XX so expect XXXX. first $XX expect the our and mind in Keep million funded million of revolver, million adjusted in Those by interest between that the $X.X X interest expense expense between quarters be of that have and $X.X to
adjusted to be tax around the expect effective We in XX.X% rate XXXX.
the first first XX%. half, expected expect we representing $X.XX half between and is and to to QX we the and XXXX be gross expect higher XX% EPS margin be adjusted will We growth throughout interest between and $X.XX, $X.XX $X.XX. be $X.XX to adjusted EPS the year to expense and between $X.XX, be between in in Because build and expect in
$XX and flow putting $XXX million expect EBITDA XXXX million cash in range, We operating XXXX. million. be full and $XXX $XXX $XX between between the million million, capital cash expenditures free million to $XXX with in year $XXX for between to We and million $XXX flow adjusted million project
the our the Xs cash leverage of Given stay relatively requirements and X the months beginning heavier in end next the drop XXXX. ratio to year, the we then for flat of expect into low by the
performance your delivering back And profitability As Curt the XXXX remain to said, with Jonathan. I'll and we our XXXX. like strong to while our are are long in we'd driving innovation focused term. growth to open over customers deliver on our hand call a pleased above-market and ability with questions, to We and it record-setting that, confident the to
